Iran's Cancer Crisis: Escalating Rates Linked to Environmental Decline and Policy Failures

Iran is currently facing a severe cancer crisis, marked by a sharp increase in cases, a decrease in the age at which patients are diagnosed, and a growing shortage of essential medicines. This alarming situation has prompted urgent warnings from medical professionals and even officials within the regime. Experts describe this scenario as “a serious alarm for the future of public health,” driven by various factors including environmental pollution, declining food quality, early tobacco use, and persistent failures in health policy.

In a strong official response, Hossein Emami-Rad, a member of the regime from Chenaran, Torghabeh, Shandiz, and Golbahar, has called for the immediate formation of a national task force aimed at cancer prevention and control. In his letter to Masoud Pezeshkian, he emphasized the need for:

Expanded free screening for early detection.
Improved access to standard medications.
Strengthened preventive programs to combat rising cancer rates.

According to data from the Ministry of Health, nearly 390 people in Iran are diagnosed with cancer every day, with approximately 200 fatalities—figures likened to “a passenger plane crash every day.” This alarming statistic underscores the urgent need for intervention.

Experts have identified a wide array of contributors to the rise in cancer cases, including:

Tobacco use
Air and water pollution
Hazardous agricultural chemicals
Unhealthy diets
Low physical activity
Obesity
Chronic stress
Weak preventive policies

Many of these factors are linked to the regime’s long-standing mismanagement and inadequate regulation concerning environmental standards. Health specialists argue that years of unregulated construction, pollution, and poor oversight have transformed the Iranian landscape into a high-risk environment for cancer.

The pace of this cancer increase has deepened concerns among experts. Current projections indicate that within the next fifteen years, Iran is likely to exceed global averages for both cancer incidence and mortality rates. The Ministry of Health’s Center for Non-Communicable Diseases predicts that by 2040, cancer incidence in Iran will rise 1.9 times, compared to a global increase of 1.5 times. Furthermore, cancer-related deaths in Iran are projected to double, far exceeding the global forecast of a 1.6-fold increase. If the current rate of 200 daily cancer-related deaths persists, this figure could escalate to 400 by 2040, equating to approximately 146,000 deaths annually.

Several provinces have already reached critical thresholds for cancer incidence. For instance:

Ardabil, Zanjan, East and West Azerbaijan, Razavi Khorasan, and North Khorasan report the highest rates of gastrointestinal cancers, with over 30 cases of stomach cancer per 100,000 people.
Kurdistan, Ilam, Mazandaran, Golestan, Kohgiluyeh and Boyer-Ahmad, Semnan, and Lorestan also fall within high-incidence areas.

Gastrointestinal cancers are particularly lethal in Iran, accounting for 27 percent of all cancer deaths, with stomach cancer alone responsible for 16 percent. Geographical data from 2020 further emphasizes the urgency of this crisis:

Yazd, Zanjan, and West Azerbaijan have the highest overall cancer incidence.
Among men, Zanjan, North Khorasan, and Ardabil show the highest rates of stomach cancer, while Fars, Yazd, and Tehran have the most prostate cancer cases.
For women, Tehran, Semnan, and Yazd report the highest breast cancer rates, with Semnan, Yazd, and Tehran leading in colorectal cancer.

One of the most concerning trends is the declining age of cancer diagnosis. Mohammad-Esmail Akbari, head of the Cancer Research Center, revealed that the average age of cancer onset in Iran is now ten years younger than the global average. With only 5–6 percent of cancers linked to genetics, he emphasized that “95 percent are tied to environment and lifestyle,” including factors such as:

Polluted air
Processed foods
Contaminated water
Chronic stress
Reduced physical activity

Additionally, Iraj Khosronia, head of the Society of Internal Medicine Specialists, has noted that “one in five people under 50 is now diagnosed with cancer,” a significant increase from one in ten just a decade ago. This trend is evident across various cancer types, including breast cancer, where diagnoses in some cities now occur as early as age 30. There is also a troubling rise in cases among children, with around 3,000 diagnosed annually—primarily with acute lymphoblastic leukemia, brain tumors, kidney cancers, and malignant nervous system tumors. This alarming trend highlights that the crisis extends far beyond adults and reflects systemic environmental and structural failures.

Compounding this already critical situation is Iran’s worsening medicine crisis. In recent months, patients have found themselves facing exorbitant prices for essential medications, leading many to resort to counterfeit or unregulated herbal products. Ahmad Aryaeinejad, MP for Malayer, confirmed that the soaring costs of medicine and medical consultations have pushed some families to abandon treatment altogether. He noted that many patients simply “give up on going to the doctor or taking medication” due to financial pressures.

Medical experts are sounding the alarm that without immediate reforms, cancer mortality could surpass current projections. Some fear that if health policies continue on their current trajectory, cancer may soon become the leading cause of death in Iran, potentially overtaking cardiovascular diseases—a scenario some describe as a looming “cancer tsunami.”

In conclusion, the data collectively reveal that the cancer crisis in Iran is not merely a medical challenge; it is the culmination of years of policy failures, rising economic inequality, environmental degradation, and a collapsing pharmaceutical system. Without urgent structural reforms, cancer may emerge as the most devastating health threat facing the Iranian population in the coming decade.